...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

Fuzzy

Don't worry - DM stated Zenith shareholders would be receiving a dividend  payout this coming February - possibly sooner - he just needs a little cash and a couple of months to finalize the deal.

Share
New Message
Please login to post a reply